(RS) -CPP

• Description :

  (RS) -CPP ((±) -CPP) is a potent and selective NMDA antagonist. (RS) -CPP inhibits central neuron responses, and has anticonvulsant activity[1].

• Product Name Alternative :

  (±) -CPP

• UNSPSC :

  12352005

• Hazard Statement :

  H315-H319-H335

• Target :

  IGluR

• Type :

  Reference compound

• Related Pathways :

  Membrane Transporter/Ion Channel; Neuronal Signaling

• Applications :

  Neuroscience-Neurodegeneration

• Field of Research :

  Neurological Disease

• Assay Protocol :

  https://www.medchemexpress.com/rs-cpp.html

• Purity :

  99.0

• Solubility :

  H2O : 99.2 mg/mL (ultrasonic)

• Smiles :

  O=C(C1NCCN(CCCP(O)(O)=O)C1)O

• Molecular Formula :

  C8H17N2O5P

• Molecular Weight :

  252.20

• Precautions :

  P261-P264-P271-P280-P302+P352-P304+P340-P362+P364-P405-P501

• References & Citations :

  [1]J Davies, et al. CPP, a new potent and selective NMDA antagonist. Depression of central neuron responses, affinity for [3H]D-AP5 binding sites on brain membranes and anticonvulsant activity. Brain Res. 1986 Sep 10;382 (1) :169-73.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [100828-16-8]